Transforming Rhythm Management: The Rapid Rise of Pulsed Field Ablation

Join leading experts from IQVIA as they explore the accelerating adoption of pulsed field ablation (PFA) in cardiac rhythm management. This webinar highlights the latest clinical data, real-world outcomes, and market trends driving the future of atrial fibrillation care.

Featured Speakers:

Joe McGonigle, PhD
Senior Principal, US MedTech Real World Evidence

Joe leads real world evidence (RWE) consulting practice for US MedTech. He advises medical device and diagnostic clients on using RWE approaches to achieve business goals across the product lifecycle including solving commercial, regulatory and reimbursement challenges. Aligns IQVIA internal datasets and solutions to deliver RWE fit for purpose for medical technology clients.

Kyle Biesecker, PhD
Principal, US MedTech Commercial Strategy Consulting Lead

Kyle collaborates with IQVIA’s data, analytics, and market insight teams to help MedTech clients design strategies to address their most pressing market challenges. He has nearly a decade of experience in strategy roles within MedTech and the Life Sciences. Most recently, he spent 2.5 years in a large consulting firm managing MedTech strategy consulting projects.

Robert Kazmierski, Ph.D.
Vice President, Electrophysiology and Cardiovascular Monitoring, MCRA, an IQVIA business

Robert specializes in developing and refining strategy for Cardiovascular Monitoring and Implantable Electrophysiology devices. He has extensive experience navigating the complex predicate landscape within the cardiac diagnostics space, especially AI algorithms for patient monitoring or disease prediction as well as heart failure diagnosis and monitoring. Robert worked for over 10 years in the Division of Cardiovascular Electrophysiology, Diagnostics, and Monitoring within the Office of Cardiovascular Devices at FDA, most recently as the Team Lead and Acting Assistant Director for the Hemodynamic and Heart Failure Diagnostics Team.